BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6810384)

  • 1. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium).
    Makheja AN; Bailey JM
    Prostaglandins Leukot Med; 1982 Jun; 8(6):653-60. PubMed ID: 6810384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets.
    Loesche W; Groenewegen WA; Krause S; Spangenberg P; Heptinstall S
    Biomed Biochim Acta; 1988; 47(10-11):S241-3. PubMed ID: 3248111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid metabolism in the neonatal platelet.
    Stuart MJ; Allen JB
    Pediatrics; 1982 Jun; 69(6):714-8. PubMed ID: 6804924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
    Lösche W; Michel E; Thielmann K; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes.
    Heptinstall S; White A; Williamson L; Mitchell JR
    Lancet; 1985 May; 1(8437):1071-4. PubMed ID: 2860288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and effects of some garlic components on platelet aggregation and metabolism of arachidonic acid in human blood platelets.
    Srivastava KC; Justesen U
    Wien Klin Wochenschr; 1989 Apr; 101(8):293-9. PubMed ID: 2499123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feverfew--an antithrombotic drug?
    Loesche W; Mazurov AV; Voyno-Yasenetskaya TA; Groenewegen WA; Heptinstall S; Repin VS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):181-4. PubMed ID: 2459017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee extracts inhibit platelet aggregation in vivo and in vitro.
    Bydlowski SP; Yunker RL; Rymaszewski Z; Subbiah MT
    Int J Vitam Nutr Res; 1987; 57(2):217-23. PubMed ID: 3115908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.
    Groenewegen WA; Heptinstall S
    J Pharm Pharmacol; 1990 Aug; 42(8):553-7. PubMed ID: 1981582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism.
    Srivastava KC
    Biomed Biochim Acta; 1984; 43(8-9):S335-46. PubMed ID: 6440548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onion exerts antiaggregatory effects by altering arachidonic acid metabolism in platelets.
    Srivastava KC
    Prostaglandins Leukot Med; 1986 Sep; 24(1):43-50. PubMed ID: 3094033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
    Piela-Smith TH; Liu X
    Cell Immunol; 2001 May; 209(2):89-96. PubMed ID: 11446741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the mechanism by which garlic inhibits platelet aggregation.
    Srivastava KC
    Prostaglandins Leukot Med; 1986 Jun; 22(3):313-21. PubMed ID: 3088604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
    Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
    J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.